Temple Device, AI, Gadgets, Healthcare, Mobile, Startups

Is the Temple Device a Scam or the Future? TheLiverDoc and Zomato Founder Clash Online

Zomato’s founder just told doctors to “keep raging” over his ₹85,000 Temple device, and the doctors are not staying quiet. Here’s what is going on.

The Temple device, a ₹85,000 wearable from Zomato and Eternal founder Deepinder Goyal, has become the centre of a loud online fight. Goyal and hepatologist Dr Cyriac Abby Philips, popularly known as TheLiverDoc, have been trading sharp words on X, and neither seems ready to back down.

A Clip on Your Head That Claims to Read Your Brain

Temple is a small, pill-shaped sensor that sticks to the side of your head. According to Goyal, it tracks blood flow in the brain in real time, a bit like a “miniaturised” MRI. The company’s website calls it a device for continuous cerebral blood flow monitoring.

It also uses a measure called “Entropy,” which the company says shows how hard your body works to shed heat. Resting Entropy and Entropy Max together make a single score called Span. Pre-orders for Batch 01 were announced to open on 1 November.

The row began when Goyal addressed “concerned Indian doctors” and said that if Temple were a scam, people would find out within days of using it. He signed off by telling critics to keep raging. A separate jab, saying “holier-than-thou” doctors could skip his next post, did not help.

“A Word Salad,” Says TheLiverDoc

Philips hit back hard, calling Goyal’s explanation a word salad with no real proof. He argued that the device can only pick up blood flow and flushing in the face, not the brain.

“Temple device is a scam. There is no doubt about it,” Philips wrote, accusing the team of misleading buyers. He also claimed the company’s own science lead had accepted that the device is not yet proven to measure brain flow or Entropy.

Is Temple a Medical Device or Not?

Goyal says no. In a Diwali post, he described Temple as a fitness and AI device and said it makes no medical claim. It does not diagnose or prevent any disease, he explained, and it cannot replace a doctor’s visit. He also said brain flow is not the main point of Temple. The objective of Temple is entropy, although there is nothing published on it.

Why Is the Price Raising Eyebrows?

Goyal said the device is “made for the world,” not just India, and expects no more than 1% of sales to come from here. He asked buyers upset about the price to wait for user reviews. He also said nobody should back Temple just because it is an Indian startup.

Goyal promised a detailed note on how Temple calculates brain flow, along with its limits. If Entropy studies are published and peer reviewed, they could settle some doubts or deepen them. As Business Fortune observes, the first real users will decide whether Temple becomes a must-have gadget or a costly curiosity.